AstraZeneca CEO doubles down on U.S. amid rumors of listing shift (2025-07-29)
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was \rapidly transferring manufacturing\" across the Atlantic."